InsiderTrades

Form 4/A for AGL agilon health, inc.

Accepted 2023-06-16 00:00:00 ET · period of report 2023-04-14 · accession 0001019056-23-000278 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DA 2023-06-16 2023-04-14 AGL Sell Steven CEO, Pres, Dir A - Grant $0.00 +39.5K 88.3K +81% $0
DA 2023-06-16 2023-04-14 AGL Sell Steven CEO, Pres, Dir F - Tax $28.46 -4,216 84.1K -5% -$120.0K
DA 2023-06-16 2023-04-14 AGL Sell Steven CEO, Pres, Dir A - Grant $0.00 +68.3K 68.3K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-04-14 A A 39,530 $0.00 88,295 D — — (F2) This Form 4/A amends a Form 4 filed by the reporting person on April 18, 2023 (the "Original Form 4"), which reported a grant of restricted stock units on April 14, 2023. The Original Form 4 erroneously reported a grant of 35,138 restricted stock units, rather than the actual grant of 39,530 restricted stock units. This error in the Original Form 4 has been corrected in this Form 4/A. (F1) Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. (F3) Includes restricted stock units.
2 Common Common Stock 2023-04-14 F D 4,216 $28.46 84,079 D — — (F4) Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. (F2) This Form 4/A amends a Form 4 filed by the reporting person on April 18, 2023 (the "Original Form 4"), which reported a grant of restricted stock units on April 14, 2023. The Original Form 4 erroneously reported a grant of 35,138 restricted stock units, rather than the actual grant of 39,530 restricted stock units. This error in the Original Form 4 has been corrected in this Form 4/A. (F3) Includes restricted stock units.
3 Derivative Options (Right to buy) 2023-04-14 A A 68,348 $0.00 68,348 D $28.46 · — to 2033-04-14 68,348 Common Stock (F5) The Original Form 4 erroneously reported that a stock option grant to the reporting person on April 14, 2023 was for 60,754 share of Common Stock, rather than the actual stock option grant for 68,348 shares of Common Stock. This error on the Original Form 4 has been corrected in this Form 4/A. (F6) Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.